What We Do
We work with oncology programs that are making decisions with real capital consequences: new equipment, new service lines, joint ventures, vendor renegotiations, AI investments. Our job is to validate those decisions before commitments are locked in, using financial modeling that holds up under scrutiny and operational planning that accounts for who is actually staffing and supervising the work.​
​
We help oncology leaders validate the assumptions behind capital, AI, and growth decisions before they become irreversible.
Capital Strategy & Vendor Alignment
We work with your vendors, not against them. Drawing on billions in past transactional experience, we partner with you to define the optimal configurations and packages that maximize the value of your capital and service negotiations. We sit on your side of the table so you never negotiate alone, ensuring that your business plans are sound and your organization is set up for long-term commercial success.
Operational Excellence & Accreditation
We map the entire Radiation Oncology operation to find where revenue is leaking. Machine uptime is the obvious one. The less obvious gaps are in scheduling inefficiency, underused treatment capacity, and billing codes that never get captured. We rely on our Network of active Radiation Oncology Administrators to provide a roadmap that not only optimizes clinical operations but prepares your program for APEx and ACR accreditation with confidence.
Service Line Growth
A proforma does not launch a service line. Staffing it does. Supervising it does. Scheduling it without breaking something else does. We build out theranostics, benign disease, and adaptive therapy programs from the business case through the operational structure required to actually run them. We do not just talk about growth; we walk through the implementation, and the organizational design, hand-in-hand with your team.
AI Reality Check
Every vendor has an AI story. Most of those stories skip the part about who runs the workflow, what the integration actually requires, and whether the clinical output changes anything you bill for. We evaluate AI claims against your specific staffing model, treatment volume, and reimbursement structure so you know whether a tool generates value or just generates slides.